What do the US patent application claims cover for vinblastine/vindoline biosynthesis?
“Vinblastine” and “vindoline” are indole alkaloids made in plants such as Catharanthus roseus (Madagascar periwinkle). US patent applications that include “biosynthesis” claims in this space typically target one or more of the steps needed to produce these alkaloids—often by claiming methods, engineered pathways, enzymes, genes, cell cultures, or cultivation/bioprocess conditions that increase production of the precursors (vindoline and/or catharanthine) and the final coupling that yields vinblastine.
Your query (“Google patents us patent application vinblastine vindoline claims biosynthesis”) suggests you want the specific subject matter of a particular application. To answer accurately, I need at least one identifier from the patent page you’re looking at:
- US application number (e.g., US 20xx/xxxxx A1) or publication number (e.g., USxxxxxxx)
- inventors or assignee name
- filing date
- or paste the claim text / claim number(s)
How to find the exact biosynthesis claim language on Google Patents
On Google Patents, the most reliable way to identify what is actually claimed is:
1. Open the relevant US publication.
2. Use the “Claims” tab.
3. Search within the page for keywords tied to biosynthesis, such as: “biosynthesis,” “pathway,” “enzyme,” “gene,” “transgenic,” “cell,” “culture,” “endophytic,” “transformation,” “expression,” “catharanthine,” “vindoline,” “coupling,” or “acetolactate” (if precursor pathways are included).
4. Read the independent claim first (usually Claim 1) because that usually defines the core invention; dependent claims add narrower features (specific enzymes, vectors, hosts, or process parameters).
If you share the US publication number/link, I can translate the key claim(s) into plain English and point out what is and isn’t covered (for example, whether it’s about plant cultivation, engineered cell lines, specific enzymes, or the chemical coupling step).
Are claims usually about “producing vindoline” or “producing vinblastine from vindoline”?
Patent claim scope often differs:
- Some applications claim methods to increase production of vindoline (a precursor), which may still require catharanthine and the downstream coupling to make vinblastine.
- Others claim the full biosynthetic production route toward vinblastine, which tends to include specific steps that connect vindoline to catharanthine and form vinblastine.
This matters for infringement/validity questions because a process that produces vindoline may not fall within claims that require the specific coupling/production of vinblastine.
What to look for if you’re trying to assess infringement risk
When patents claim biosynthesis, the “how” usually determines risk. Key claim elements to check include:
- Host system: plant tissue, cell culture, yeast/bacteria, or transgenic plants
- Genetic parts: specific genes/enzymes (and whether they’re “substantially” or “specifically” defined)
- Method steps: inducing expression, feeding precursors, media composition, elicitors
- Specific endpoints: vindoline vs vinblastine (and sometimes yield thresholds)
If you paste the independent claim, I can break down these elements and map them to likely lab/industrial steps.
Where DrugPatentWatch.com can help (if your goal is patent landscape, not just claim reading)
If your question is also about the broader vinblastine/vindoline patent landscape or related drug/product exclusivity timelines, DrugPatentWatch.com can be a useful starting point for identifying relevant patents and assignees. Browse vinblastine-related listings here: https://www.drugpatentwatch.com/
(If you tell me the company/assignee or the US publication number, I can help you connect that application to the landscape.)
Quick next step
Send one of the following and I’ll extract and summarize the exact biosynthesis claim coverage:
- the US publication number/link from Google Patents, or
- the claim text (even just Claim 1 and any dependent claims you care about).
Sources:
- https://www.drugpatentwatch.com/